MedicarePartD.guide

A non-government resource built from CMS public data

Nucala on AARP Medicare Rx Preferred from UHC (S5921-391)

mepolizumab

Covered, with prior authorization required.

Tier 5 (specialty tier). Quantity limit of 0.4 per 28 days.

$554.63
Patient pays / month, after deductible
$644.33
Patient pays / month, before the $130.00 deductible
Not offered
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap

NUCALA 40 mg/.4mL Injection, Solution at a preferred retail pharmacy, from the plan's negotiated price of $1,789.14 for a month. Other covered strengths are listed below.

Prior authRequired on all 4 covered forms· The plan decides within 72 hours, or 24 if expedited· If denied, the prescriber can ask the plan to reconsider (an appeal)
All 4 covered strengths and forms
FormTierPatient pays / monthLimits
NUCALA 100 mg/mL Injection, Powder, For Solution5$3,634.28PA · 3 per 28 days
NUCALA 100 mg/mL Injection, Solution5$3,719.04PA · 3 per 28 days
NUCALA 100 mg/mL Injection, Solution5$3,719.04PA · 3 per 28 days
NUCALA 40 mg/.4mL Injection, Solution5$554.63PA · 0.4 per 28 days

Other Asthma and COPD biologics on this plan

Verify with the plan before prescribing or filling. Member services: (866)870-3470. Data from the CMS 2026 Part D formulary and pricing files. Full plan details

Plan ID s5921-391